Perfluorohexyloctane

7.1 The PBAC recommended a General Schedule and an Optometric Schedule Authority Required (STREAMLINED) listing of perfluorohexyloctane for the treatment of severe dry-eye syndrome in patients who are sensitive to preservatives in multi-dose eye drops.PSD · Mar 2018

7.2 The PBAC noted that the submission did not specify the maximum quantity or number of repeats for the proposed restriction. The PBAC considered that the maximum quantity should be consistent with other multi-dose preservative-free ocular lubricants on the PBS with a maximum quantity of 1 and the number of repeats should be limited to 5.PSD · Mar 2018

6.5 The submission did not specify a particular economic analysis, it presented a cost comparison across a number of PBS listed preservative-free ocular lubricants and perfluorohexyloctane (Table 1) with a proposed AEMP of $'''''''''''.PSD · Mar 2018

6.6 The submission stated that due to the nature of packaging of preservative-free ocular lubricant solutions, the majority of PBS listed items are available in single use containers to prevent contamination. The Sponsor stated that single use containers may contain an excess ocular lubricant solution, and are associated with unnecessary wastage and higher treatment costs. 3PSD · Mar 2018

6.2 The PBAC noted that there was no consumer comment for this submission.PSD · Mar 2018